IN2015DN04207A - - Google Patents

Info

Publication number
IN2015DN04207A
IN2015DN04207A IN4207DEN2015A IN2015DN04207A IN 2015DN04207 A IN2015DN04207 A IN 2015DN04207A IN 4207DEN2015 A IN4207DEN2015 A IN 4207DEN2015A IN 2015DN04207 A IN2015DN04207 A IN 2015DN04207A
Authority
IN
India
Prior art keywords
neurologic component
nervous system
nutritional compositions
brain
subjects
Prior art date
Application number
Other languages
English (en)
Inventor
Chenzhong Kuang
Yan Xiao
Eduard K Poels
Zeina Jouni
Dirk Hondmann
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of IN2015DN04207A publication Critical patent/IN2015DN04207A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
IN4207DEN2015 2013-01-11 2013-12-12 IN2015DN04207A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/739,787 US20140199265A1 (en) 2013-01-11 2013-01-11 Nutritional compositions containing a neurologic component and uses thereof
PCT/US2013/074521 WO2014109862A1 (en) 2013-01-11 2013-12-12 Nutritional compositions containing a neurologic component and uses thereof

Publications (1)

Publication Number Publication Date
IN2015DN04207A true IN2015DN04207A (ru) 2015-10-16

Family

ID=49887324

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4207DEN2015 IN2015DN04207A (ru) 2013-01-11 2013-12-12

Country Status (16)

Country Link
US (1) US20140199265A1 (ru)
EP (1) EP2943079A1 (ru)
CN (1) CN104883909A (ru)
AR (1) AR094413A1 (ru)
AU (1) AU2013372898B2 (ru)
BR (1) BR112015016358A2 (ru)
CA (1) CA2912246A1 (ru)
HK (1) HK1214090A1 (ru)
IN (1) IN2015DN04207A (ru)
MX (1) MX2015008585A (ru)
PE (1) PE20151771A1 (ru)
PH (1) PH12015501504A1 (ru)
RU (1) RU2015120263A (ru)
SG (1) SG11201503682VA (ru)
TW (1) TW201440669A (ru)
WO (1) WO2014109862A1 (ru)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980506B2 (en) 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US9661874B2 (en) 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9241923B2 (en) 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9226914B2 (en) 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10028519B2 (en) * 2014-03-05 2018-07-24 Mead Johnson Nutrition Company Nutritional compositions containing ceramide and uses thereof
US20150305359A1 (en) * 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
US20160095339A1 (en) * 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
CN106998774A (zh) * 2014-11-26 2017-08-01 雅培制药有限公司 包含人乳低聚糖、多不饱和脂肪酸、核苷酸以及叶黄素的婴儿配方
US10617701B2 (en) * 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US20170006897A1 (en) * 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
EP3389409A1 (en) * 2015-12-14 2018-10-24 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
AU2016374155A1 (en) * 2015-12-14 2018-04-19 Société des Produits Nestlé S.A. Nutritional composition and infant formula for promoting myelination of the brain
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
CN105638906A (zh) * 2016-01-11 2016-06-08 东北农业大学 一种满足婴儿的脂质个性化营养需求的婴儿配方奶粉
WO2017176109A1 (en) 2016-04-04 2017-10-12 N.V. Nutricia Method for reducing or preventing global developmental delay in children
CN110325054A (zh) * 2017-05-04 2019-10-11 小利兰·斯坦福大学托管委员会 促进神经发育的食物组合物和与其相关的试剂盒、系统和方法
US20200208103A1 (en) * 2017-07-20 2020-07-02 Riken Method for maturation of retinal tissue containing continuous epithelium
WO2019074617A2 (en) * 2017-09-14 2019-04-18 Kilman Clarke Lewis NEUPANEX ®: NEUROGENESIS, NEUROREGENERATIONAL AND NEUROPROTECTIVE SUPPLEMENT SUPPLEMENT COMBINATION
US11357803B2 (en) * 2017-09-22 2022-06-14 Iowa State University Research Foundation, Inc. Probiotic compositions for production of dopamine
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
MX2020006768A (es) 2017-12-29 2020-08-24 Kraft Foods Group Brands Llc Estabilidad oxidativa mejorada de emulsiones de aceite-en-agua utilizando estabilizadores naturales.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143234B2 (en) * 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
US20050013884A1 (en) * 2003-07-16 2005-01-20 Rennels M. Scott Compositions and methods for treating heart disease
ES2314461T3 (es) * 2003-10-24 2009-03-16 N.V. Nutricia Composicion simbiotica para bebes.
TW200628075A (en) * 2004-10-12 2006-08-16 Katrina Fletcher Dairy product and process
AU2012203650B2 (en) * 2005-05-23 2014-09-18 Massachusetts Institute Of Technology Compositions containing PUFA and methods of use thereof
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
US20130172286A1 (en) * 2010-03-31 2013-07-04 Vegenat, S.A. Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma

Also Published As

Publication number Publication date
EP2943079A1 (en) 2015-11-18
BR112015016358A2 (pt) 2017-07-11
CN104883909A (zh) 2015-09-02
HK1214090A1 (zh) 2016-07-22
AR094413A1 (es) 2015-07-29
AU2013372898B2 (en) 2016-12-08
PH12015501504A1 (en) 2015-09-28
CA2912246A1 (en) 2014-07-17
WO2014109862A1 (en) 2014-07-17
AU2013372898A1 (en) 2015-05-28
MX2015008585A (es) 2015-09-04
RU2015120263A (ru) 2017-02-16
SG11201503682VA (en) 2015-06-29
PE20151771A1 (es) 2015-12-02
US20140199265A1 (en) 2014-07-17
TW201440669A (zh) 2014-11-01

Similar Documents

Publication Publication Date Title
IN2015DN04207A (ru)
HK1256856A1 (zh) 用於抗病毒治療的2'-取代的卡巴-核苷類似物
EP3653111C0 (en) DEVICE FOR PROVIDING STIMULI TO THE BRAIN
BR112017019409A2 (pt) forma cristalina de ribosídeo de nicotinamida
EP3057654A4 (en) Brain stimulation system including diagnostic tool
HK1222514A1 (zh) 增强腦發育的營養組合物
IL251353A0 (en) New histories of 2' and/or 5' amino acid ester phosphoramidate 3'-deoxy adenosine as anticancer compounds
BR112015026660A2 (pt) ligas metálicas aperfeiçoadas para dispositivos médicos
PH12016500082A1 (en) Method for promoting neuronal development and/or health
EA034135B9 (ru) Фармацевтические композиции на основе производных уридиновых нуклеозидов в качестве агонистов pyрецепторов
ZA201803483B (en) Method of treating disease by auricular anesthesia of cranial nerves
EP2946792A4 (en) THERAPEUTIC AGENT AND THERAPY PROCEDURE WITH 1,25D3 MARRS FOR NEUROLOGICAL ILLNESSES SUCH AS MORBUS ALZHEIMER
IL246254A0 (en) Compounds of omega-3 fatty acids for the treatment of diseases involving damage to the nervous system
ZA201407010B (en) Process for the preparation of branched polybutadiene having high content of 1,4-cis units
EP2987493A4 (en) COMPOSITION FOR PREVENTING OR TREATING A CEREBRAL VASCULAR OR DEGENERATIVE BRAIN DISEASE
PH12015502727A1 (en) Methods and compositions for enhancing cognitive performance
FR2999156B1 (fr) Procede de securisation d'un aeronef
ECSP15034791A (es) Composiciones nutricionales que contienen un componente neurológico, y sus usos
CL2016000586A1 (es) Composición que comprende fósforo para uso en prevenir deformidades en peces triploides
TH159964B (th) องค์ประกอบทางโภชนาการที่มีส่วนประกอบที่เกี่ยวกับระบบประสาท และการใช้ของมัน
TWM475825U (en) Extraction system for yolk oil as cranial nerve nutrition supplement for improving insomnia
BR112015032201A2 (pt) processo para produzir um cacau natural castanho escuro
PL3423441T3 (pl) Jodowane analogi choliny, sposoby ich przygotowywania oraz zastosowanie jako leki
TH1401006299A (th) กระบวนการสำหรับการเตรียมของพอลิบิวทาไดอีนแบบกิ่งสาขาซึ่งมีปริมาณสูงของหน่วย 1,4-ซิส
BR102013001909A8 (pt) Estrutura de gaveta